Lung Cancer
Conditions
Interventions
Sevoflurane+TPVB:Sevoflurane+TPVB
Sevoflurane+Optimized TPVB:Sevoflurane+Optimized TPVB
Propfol:Propofol
Propofol+TPVB:Propofol+TPVB
Propofol+Optimized TPVB:Propofol+Optimized TPVB
Sponsors
Henan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with elective thoracoscopic radical lung cancer surgery; 2. Aged 18-64 years, body mass index 18-25kg/m2; 3. ASA grade II or III; 4. 80% estimated value of forced lung capacity >, 70% estimated value of expiratory rate > in the first second; 5. Definite preoperative diagnosis of lung cancer, tumor diameter greater than 1cm. 6. Willing to participate in the trial and sign infored consent.
Exclusion criteria
Exclusion criteria: 1. Communication disorders, inability to cooperate with researchers, such as language comprehension disorders, mental disorders, etc.; 2. Preoperative history of chemoradiotherapy; 3. Serious cardiovascular and cerebrovascular diseases; 4. History of diabetes, blood diseases and other metabolic disorders; 5. History of hypertension, no chronic obstructive or (and) restrictive lung disease; 6. Smoking history within 2 weeks before surgery; 7. Previous history of other operations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stay duration in hospital; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease-free survival;Overall survival;Life quality;postoperative complications;Patient Satisfaction;Incidence of chronic pain;Hospital cost;Tumor microenviromental marker; | — |
Countries
China
Contacts
Public ContactZhang Wei
Henan Provincial People's Hospital
Outcome results
None listed